HOPMAN MARK (Chief Commercial Officer) sold 1.0% of their position (1.26K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $18.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2026ACC: 0002048497-26-000009
Officer· Chief Commercial Officer
Since Mar 2026
-1.26K
Net shares
Net seller
$18.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.26K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.26K
Price / share
$15.01
Trade value
$18.88K
% of position
1.0%
6/24/2026
130.61K→129.35K
Total
Net shares
−1.26K
Net value
-$18.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/24/2026 | S · Sale | −1.26K | $15.01 | $18.88K | 1.0% | 130.61K | 129.35K |
| Total | −1.26K | -$18.88K | ||||||
Derivative Transactions0
No derivative transactions reported